CLINICAL_TRIALS
trial_result
· 2012-08-16
Clinical Trial Update: Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection [Phase 3]
Summary
Phase 3 trial evaluating Everolimus for preventing acute and chronic rejection in heart transplant recipients; results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Graft Rejection | Phase 3 | Status: COMPLETED | Results posted: 2012-08-16